Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis

Detalhes bibliográficos
Autor(a) principal: Pereira,Ana Maria Gomes
Data de Publicação: 2022
Outros Autores: Pannain,Gabriel Duque, Esteves,Bruna Helena Gonçalez, Bacci,Maria Luiza de Lima, Rocha,Maria Luiza Toledo Leite Ferreira da, Lopes,Reginaldo Guedes Coelho
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Einstein (São Paulo)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100410
Resumo: ABSTRACT Objective To perform a systematic review and meta-analysis of randomized clinical trials that compared the use of antibiotics versus placebo in premature rupture of membranes preterm and evaluated maternal, fetal and neonatal outcomes in pregnant women with premature rupture of ovular membranes at a gestational age between 24 and 37 weeks. Methods A search was conducted using keywords in PubMed, Cochrane, Biblioteca Virtual em Saúde and Biblioteca Digital de Teses e Dissertações da USP between August 2018 and December 2021. A total of 926 articles were found. Those included were randomized clinical trials that compared the use of antibiotics versus placebo in the premature rupture of preterm membranes. Articles referring to antibiotics only for streptococcus agalactiae prophylaxis were excluded. The retrieved articles were independently and blindly analyzed by two reviewers. A total of 24 manuscripts met the inclusion criteria and 21 articles were included for quantitative analysis. Results Among the maternal outcomes analyzed, there was a prolongation of the latency period that was ≥7 days. In addition, we observed a reduction in chorioamnionitis in the group of pregnant women who used antibiotics. As for endometritis and other maternal outcomes, there was no statistically significant difference between the groups. Regarding fetal outcomes, antibiotic prophylaxis worked as a protective factor for neonatal sepsis. Necrotizing enterocolitis and respiratory distress syndrome showed no statistically significant differences. Conclusion The study showed positive results in relation to antibiotic prophylaxis to prolong the latency period, new randomized clinical trials are needed to ensure its beneficial effect. Prospero database registration (www.crd.york.ac.uk/prospero) under number CRD42020155315.
id IIEPAE-1_86080ae4bdd73c88c3effbca86078596
oai_identifier_str oai:scielo:S1679-45082022000100410
network_acronym_str IIEPAE-1
network_name_str Einstein (São Paulo)
repository_id_str
spelling Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysisFetal membranespremature ruptureGestational agePregnant womenAntibiotic prophylaxisAnti-bacterial agentsInfantprematureABSTRACT Objective To perform a systematic review and meta-analysis of randomized clinical trials that compared the use of antibiotics versus placebo in premature rupture of membranes preterm and evaluated maternal, fetal and neonatal outcomes in pregnant women with premature rupture of ovular membranes at a gestational age between 24 and 37 weeks. Methods A search was conducted using keywords in PubMed, Cochrane, Biblioteca Virtual em Saúde and Biblioteca Digital de Teses e Dissertações da USP between August 2018 and December 2021. A total of 926 articles were found. Those included were randomized clinical trials that compared the use of antibiotics versus placebo in the premature rupture of preterm membranes. Articles referring to antibiotics only for streptococcus agalactiae prophylaxis were excluded. The retrieved articles were independently and blindly analyzed by two reviewers. A total of 24 manuscripts met the inclusion criteria and 21 articles were included for quantitative analysis. Results Among the maternal outcomes analyzed, there was a prolongation of the latency period that was ≥7 days. In addition, we observed a reduction in chorioamnionitis in the group of pregnant women who used antibiotics. As for endometritis and other maternal outcomes, there was no statistically significant difference between the groups. Regarding fetal outcomes, antibiotic prophylaxis worked as a protective factor for neonatal sepsis. Necrotizing enterocolitis and respiratory distress syndrome showed no statistically significant differences. Conclusion The study showed positive results in relation to antibiotic prophylaxis to prolong the latency period, new randomized clinical trials are needed to ensure its beneficial effect. Prospero database registration (www.crd.york.ac.uk/prospero) under number CRD42020155315.Instituto Israelita de Ensino e Pesquisa Albert Einstein2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100410einstein (São Paulo) v.20 2022reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.31744/einstein_journal/2022rw0015info:eu-repo/semantics/openAccessPereira,Ana Maria GomesPannain,Gabriel DuqueEsteves,Bruna Helena GonçalezBacci,Maria Luiza de LimaRocha,Maria Luiza Toledo Leite Ferreira daLopes,Reginaldo Guedes Coelhoeng2022-11-25T00:00:00Zoai:scielo:S1679-45082022000100410Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2022-11-25T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false
dc.title.none.fl_str_mv Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
title Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
spellingShingle Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
Pereira,Ana Maria Gomes
Fetal membranes
premature rupture
Gestational age
Pregnant women
Antibiotic prophylaxis
Anti-bacterial agents
Infant
premature
title_short Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
title_full Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
title_fullStr Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
title_full_unstemmed Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
title_sort Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
author Pereira,Ana Maria Gomes
author_facet Pereira,Ana Maria Gomes
Pannain,Gabriel Duque
Esteves,Bruna Helena Gonçalez
Bacci,Maria Luiza de Lima
Rocha,Maria Luiza Toledo Leite Ferreira da
Lopes,Reginaldo Guedes Coelho
author_role author
author2 Pannain,Gabriel Duque
Esteves,Bruna Helena Gonçalez
Bacci,Maria Luiza de Lima
Rocha,Maria Luiza Toledo Leite Ferreira da
Lopes,Reginaldo Guedes Coelho
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira,Ana Maria Gomes
Pannain,Gabriel Duque
Esteves,Bruna Helena Gonçalez
Bacci,Maria Luiza de Lima
Rocha,Maria Luiza Toledo Leite Ferreira da
Lopes,Reginaldo Guedes Coelho
dc.subject.por.fl_str_mv Fetal membranes
premature rupture
Gestational age
Pregnant women
Antibiotic prophylaxis
Anti-bacterial agents
Infant
premature
topic Fetal membranes
premature rupture
Gestational age
Pregnant women
Antibiotic prophylaxis
Anti-bacterial agents
Infant
premature
description ABSTRACT Objective To perform a systematic review and meta-analysis of randomized clinical trials that compared the use of antibiotics versus placebo in premature rupture of membranes preterm and evaluated maternal, fetal and neonatal outcomes in pregnant women with premature rupture of ovular membranes at a gestational age between 24 and 37 weeks. Methods A search was conducted using keywords in PubMed, Cochrane, Biblioteca Virtual em Saúde and Biblioteca Digital de Teses e Dissertações da USP between August 2018 and December 2021. A total of 926 articles were found. Those included were randomized clinical trials that compared the use of antibiotics versus placebo in the premature rupture of preterm membranes. Articles referring to antibiotics only for streptococcus agalactiae prophylaxis were excluded. The retrieved articles were independently and blindly analyzed by two reviewers. A total of 24 manuscripts met the inclusion criteria and 21 articles were included for quantitative analysis. Results Among the maternal outcomes analyzed, there was a prolongation of the latency period that was ≥7 days. In addition, we observed a reduction in chorioamnionitis in the group of pregnant women who used antibiotics. As for endometritis and other maternal outcomes, there was no statistically significant difference between the groups. Regarding fetal outcomes, antibiotic prophylaxis worked as a protective factor for neonatal sepsis. Necrotizing enterocolitis and respiratory distress syndrome showed no statistically significant differences. Conclusion The study showed positive results in relation to antibiotic prophylaxis to prolong the latency period, new randomized clinical trials are needed to ensure its beneficial effect. Prospero database registration (www.crd.york.ac.uk/prospero) under number CRD42020155315.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100410
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100410
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.31744/einstein_journal/2022rw0015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
dc.source.none.fl_str_mv einstein (São Paulo) v.20 2022
reponame:Einstein (São Paulo)
instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
instname_str Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron_str IIEPAE
institution IIEPAE
reponame_str Einstein (São Paulo)
collection Einstein (São Paulo)
repository.name.fl_str_mv Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
repository.mail.fl_str_mv ||revista@einstein.br
_version_ 1752129911290593280